✦ LIBER ✦

P381 Predictors and frequency of anti-TNF dose escalation in patients with inflammatory bowel disease

✍ Scribed by Viazis, N.; Koukouratos, T.; Anastasiou, J.; Saprikis, E.; Kechagias, G.; Katopodi, K.; Mela, M.; Karamanolis, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P489 How often is dose escalation needed

✍ Viazis, N.; Koukouratos, T.; Saprikis, E.; Al-Odat, M.; Anastasopoulos, E.; Zach 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB

DOP085 Success rate of dose de-escalatio

✍ Viazis, N.; Anastasiou, J.; Koukouratos, T.; Giakoumis, M.; Anastasopoulos, E.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 49 KB

P448 Inflammatory and cancerous skin les

✍ Ocepek, A.; Pernat Drobez, C. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 155 KB

P539 Dose intensification with anti-TNF

✍ Kothegal Marimahadevappa, G.; Limdi, J.K. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB

P642 Frequency of tuberculosis in patien

✍ Morozova, N.; Belousova, E.; Tsodikova, O.; Tagieva, E. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 66 KB

P099 Anti-TNF-alpha treatment improves c

✍ Lorinczy, K.; Miheller, P.; Patócs, A.; Székely, H.; Reismann, P.; Csontos, Á.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 105 KB